SLC67A1 and non-small cell lung carcinoma: To evaluate whether SLC22A18 and SLC22A18AS expression levels were associated with clinical outcomes for patients with the main histological subtypes of NSCLC, we analyzed SLC22A18 and SLC22A18AS expression levels by first progression of disease and overall survival data using the KM Plotter website [18].